Alfadocs’ SaaS platform is designed to increase the efficiency of workflows in medical practices through automated processes. This should save time and money and keep patients satisfied. The Munich-based company’s platform offers appointment scheduling, findings documentation, integration of X-ray systems, and billing services.
“We are very proud that in the currently very challenging market environment for young companies, we have won two renowned venture capital firms as new investors with BayBG and Bayern Kapital. This confirms us in our vision of consistently driving the digitalization of medical practices throughout Europe”,
says Alfadocs co-founder and CEO Niklas Fischer-Riepe.
“Our customers are already benefiting from modern technology today to automate their workflows, make the right decisions, and thus provide their patients with better healthcare. With the additional funds, we want to advance our expansion and further strengthen our technological advantage, for example through the integration of third-party products into our platform.”
Alfadocs: “Convincing market proof”
Peter Graf, investment manager at BayBG, says:
“With convincing advantages such as SaaS architecture, cloud solution, and broad functionality, Alfadocs.com managed to gain a significant share of the medical practice market in its first major market, Italy, in a short time. And without extensive marketing or sales activities. That is convincing market proof that demonstrates the medium and long-term market potential.”
